Asset Management Ventures

SeeQC, Inc. is a developer of digital quantum computing platforms aimed at global businesses, with a focus on creating commercially viable application-specific quantum computing systems. Founded in 2018 and headquartered in Elmsford, New York, the company specializes in the design, testing, and manufacturing of quantum-ready superconductors. It integrates classical and quantum technologies to tackle common challenges in efficiency, stability, and cost associated with quantum computing. SeeQC's offerings include superconducting qubit chips and proprietary Single Flux Quantum (SFQ) technology, enabling high-performance classical co-processors and application-specific integrated circuits (ASICs). The company's approach combines digital readout and control technology with a unique chip-scale architecture to deliver scalable and cost-effective quantum computing solutions suitable for sectors such as machine learning, logistics optimization, quantum chemistry, pharmaceuticals, and fintech. Additionally, SeeQC operates facilities in London, United Kingdom, and Naples, Italy, enhancing its capacity to serve clients across the United States and Europe.

Medsien specializes in remote care management services that utilize artificial intelligence to enhance patient engagement and improve health outcomes. The company's platform aggregates and curates patient data, allowing healthcare providers to efficiently monitor chronic conditions and related services. By delivering real-time insights and visualizing relevant metrics, Medsien enables providers to make informed decisions quickly. This integrated approach aims to streamline operations while focusing on personalized support, ultimately enhancing the patient experience and reducing costs associated with chronic care management.

Endless Health is a comprehensive platform focused on cardiovascular health, offering users access to research-backed information about heart conditions and prevention strategies. The company facilitates connections between individuals and certified healthcare professionals through video chat and messaging, promoting accountability in managing heart health. With a user-friendly dashboard, Endless Health combines essential data and behavior tracking, allowing individuals to monitor their health journey effectively. By integrating technology with medical expertise, the platform supports early detection and personalized intervention strategies, making it easier for users to proactively manage their cardiovascular health and reduce the risk of heart-related diseases.

Basys.ai is a company that specializes in automating prior authorization and utilization management for health plans and payers through an AI-driven platform. Its proprietary technology employs machine learning to digitize and encode payer policies, significantly reducing the time needed for implementation by up to nine months. The platform aims to enhance communication between patients and healthcare providers, streamline administrative processes, and improve patient outcomes. By focusing on a data-centric approach, Basys.ai helps organizations optimize care delivery while minimizing costs associated with administrative tasks and medical procedures.

Autonomize AI is transforming the healthcare sector through its innovative AI copilots, which are designed to organize, contextualize, and summarize unstructured data. By alleviating the administrative load on healthcare professionals, these copilots facilitate quicker, data-driven decision-making that can enhance patient outcomes. The company offers features that support various aspects of healthcare, including clinical trials, drug discovery, and patient journeys, allowing professionals to easily extract relevant information from diverse healthcare data sources. As a founding member of CancerX, part of the U.S. President Biden’s Cancer Moonshot initiative, Autonomize AI is committed to advancing cancer care. The company serves a prestigious clientele that includes major pharmaceutical firms and leading life sciences organizations, using advanced technologies such as natural language processing and machine learning to set new standards in healthcare efficiency.

SubjectWell is a clinical trial marketplace focused on patient recruitment, providing a risk-free platform for healthcare clients to efficiently find and screen qualified participants for clinical trials. By streamlining the recruitment process, SubjectWell helps accelerate the completion of studies, ensuring that healthcare organizations can meet their research timelines effectively. The company specializes in delivering highly qualified referrals, thereby enhancing the overall efficiency of clinical trials and contributing to advancements in medical research.

Array Insights is an IT firm that specializes in developing artificial intelligence-driven solutions for managing sensitive healthcare data. The company's platform facilitates the secure sharing of valuable and regulated patient and caregiver stories without compromising data ownership or privacy. By employing an encrypted analytics interface, Array Insights enables hospitals to connect data algorithms, ensuring compliance and security during research activities. This approach allows healthcare organizations to track and trace patient information securely while accelerating their research efforts. Founded in 2017 and based in Cambridge, Massachusetts, Array Insights focuses on empowering businesses to leverage proprietary data safely and effectively.

Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.

LegalMate is a legal automation platform aimed at enhancing access to legal services for individuals, particularly those from low-income backgrounds. Recognizing that a significant percentage of civil legal issues go unresolved due to insufficient legal assistance, LegalMate addresses this gap by offering financing solutions that allow law firms to receive their fees upfront while adhering to regulatory guidelines. This model not only supports law firms in managing payment plans efficiently but also empowers clients to secure legal help on their own terms. By automating complex legal processes, LegalMate optimizes workflow for legal professionals, enabling them to focus on providing quality services while increasing overall efficiency.

Pluto Health is a health technology company that focuses on improving patient care through a platform designed for remote monitoring and personalized care plans. It aggregates electronic health record data from various sources, including health systems, pharmacies, and labs, to provide comprehensive insights into patients' health. The platform helps patients manage their healthcare by automating reminders for tasks such as paying bills, tracking medications, and sharing health data with providers. By unifying diverse health information, including patient-reported outcomes and social determinants of health, Pluto Health aims to identify and address gaps in care. This enables the creation of tailored care journeys and enhances access to preventive healthcare and clinical trials, ultimately delivering timely resources to patients.

Outcomes4Me Inc. is an AI-driven healthcare platform based in Cambridge, Massachusetts, founded in 2017. It focuses on empowering cancer patients by providing access to personalized, evidence-based treatment options and clinical information. The platform enables patients to navigate their care proactively, facilitating informed decision-making and improving health outcomes. By democratizing healthcare, Outcomes4Me promotes health equity and supports deeper insights into patient care, while also accelerating research and access to innovative treatments. The company is led by a team of experienced professionals from various sectors, including healthcare, oncology, and technology, dedicated to enhancing the patient experience in cancer treatment.

Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.

Array Insights is an IT firm that specializes in developing artificial intelligence-driven solutions for managing sensitive healthcare data. The company's platform facilitates the secure sharing of valuable and regulated patient and caregiver stories without compromising data ownership or privacy. By employing an encrypted analytics interface, Array Insights enables hospitals to connect data algorithms, ensuring compliance and security during research activities. This approach allows healthcare organizations to track and trace patient information securely while accelerating their research efforts. Founded in 2017 and based in Cambridge, Massachusetts, Array Insights focuses on empowering businesses to leverage proprietary data safely and effectively.

Outcomes4Me Inc. is an AI-driven healthcare platform based in Cambridge, Massachusetts, founded in 2017. It focuses on empowering cancer patients by providing access to personalized, evidence-based treatment options and clinical information. The platform enables patients to navigate their care proactively, facilitating informed decision-making and improving health outcomes. By democratizing healthcare, Outcomes4Me promotes health equity and supports deeper insights into patient care, while also accelerating research and access to innovative treatments. The company is led by a team of experienced professionals from various sectors, including healthcare, oncology, and technology, dedicated to enhancing the patient experience in cancer treatment.

Lark is a developer of a virtual chronic disease prevention and management platform that offers personalized support and counseling to users. Utilizing advanced artificial intelligence alongside human coaches and connected devices, Lark provides real-time, 24/7 assistance, helping individuals make healthier choices and manage chronic conditions effectively. The company has established CDC-recognized programs, including its Diabetes Prevention Program, Wellness Program, Diabetes Care Program, and Hypertension Program, which collectively serve 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in 11 peer-reviewed journals and analyst reports. Founded in 2011 by Julia Hu and Jeff Zira, Lark is headquartered in Mountain View, California.

Reify Health, Inc., founded in 2010 and based in Baltimore, Maryland, specializes in cloud-based software designed to enhance health behavior change measurement. Catering primarily to the life sciences industry, the company offers solutions that accelerate the development of new therapies by streamlining clinical research processes. Its flagship product, StudyTeam, supports clinical trial teams by improving enrollment timelines and research efficiency. This software provides research sponsors, contract research organizations (CROs), and clinical research sites with valuable insights into enrollment dynamics, allowing them to prioritize efforts that drive successful clinical outcomes. By reducing administrative burdens, Reify Health enables stakeholders to concentrate on activities that deliver the most significant impact on research productivity and budget management.

Unnatural Products Inc. is a biotechnology company based in Santa Cruz, California, specializing in drug discovery through the innovative use of macrocyclic peptides. Founded in 2016, the company employs artificial intelligence and computational biology techniques to engineer these peptides, allowing them to target previously undruggable protein interactions. By leveraging machine learning for parallel chemical synthesis, Unnatural Products aims to optimize macrocyclic compounds efficiently, thereby accelerating the drug discovery process. This technology addresses a significant gap in therapeutic strategies, offering potential treatments for a wide range of diseases linked to difficult-to-target drug candidates.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

UniKey Technologies, Inc. is a company that specializes in access control solutions, offering a platform that transforms smartphones into universal electronic keys. Founded in 2010 and based in Winter Park, Florida, the company provides a smart lock system that includes touch-to-open technology, allowing users to unlock doors without removing their smartphones from pockets or purses. UniKey's platform features advanced intelligence that determines whether an authorized user is present before granting access, enhancing security and preventing unauthorized entry. The company collaborates with lock manufacturers, including Kwikset and Weiser, to develop integrated smart lock solutions like Kevo. Additionally, UniKey offers a cloud-based lock management system tailored for multifamily properties and commercial businesses, which simplifies key management and access control across various applications, including residential, hospitality, and automotive sectors.

Welkin Health, Inc. is a San Francisco-based company that develops and operates patient management software designed to enhance care delivery for healthcare organizations. Founded in 2013, its platform automates workflows to guide healthcare teams, ensuring that patients receive timely and appropriate care. The software facilitates communication between health plans, providers, and patients through various channels, including phone, text, video, and email. Additionally, it supports the design and testing of care programs tailored to specific demographics and geographic regions. Welkin Health's cloud-based platform is customizable and scalable, addressing a wide range of healthcare needs such as mental health, substance abuse, diabetes, and oncology, ultimately aiming to foster meaningful relationships between healthcare teams and patients.

Mightier is a gaming platform designed to assist children in regulating their emotions through scientifically-backed methods. Founded in 2016 and based in Boston, Massachusetts, the platform features bioresponsive video games developed in collaboration with Boston Children's Hospital and Harvard Medical School. The games utilize a biofeedback heart rate monitor that adjusts the difficulty level based on the player's emotional state, helping children learn to manage their feelings in real-time. By engaging with these interactive experiences, children with behavioral and emotional challenges can discover their emotional strengths and develop skills to harness their emotions in everyday situations.

Signal Vine, Inc. is a company that develops an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. The platform features targeted messaging, an intuitive interface, case management, hybrid messaging, and comprehensive reporting and analytics. By leveraging Blended Messaging and incorporating artificial intelligence, Signal Vine enables organizations to send personalized messages to students, alumni, and staff, thereby improving engagement and supporting timely actions. The platform is utilized by K-12 schools, higher education institutions, nonprofit organizations, and government programs to enhance student outcomes, streamline communication, and foster enrollment and persistence. Founded in 2013, the company is headquartered in Alexandria, Virginia.

Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.

InCarda Therapeutics is a clinical-stage biopharmaceutical company based in Newark, California, focused on developing innovative therapies for cardiovascular diseases. The company specializes in an inhaled drug delivery system aimed at treating acute paroxysmal atrial fibrillation, allowing patients to administer treatment quickly during the onset of symptoms. Its lead product, InRhythm, is an inhaled formulation of an antiarrhythmic medication designed to provide rapid relief from arrhythmic events. This method allows for effective medication delivery directly to cardiac tissue, which enhances treatment efficacy and simplifies the management of atrial arrhythmias. InCarda Therapeutics has completed Phase 1 clinical trials and is progressing through Phase 2 with its lead product.

Properly, Inc. is a technology company that offers a platform and mobile application designed to enhance operations for vacation rental properties, including housekeeping and maintenance services. Founded in 2014 and headquartered in San Francisco, California, Properly aims to streamline the turnover process for property owners and managers by providing a visual checklist tool that facilitates clear communication of cleaning instructions to service providers. This approach ensures consistency in service delivery and helps professional cleaners understand client expectations, ultimately fostering recognition for their quality work. The company serves a diverse clientele, including property owners, managers, and service providers, all seeking to improve efficiency and effectiveness in property management.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

3T Biosciences, Inc. is an immunotherapy company established in 2017 and based in Menlo Park, California. The company focuses on developing innovative treatments for cancer and other T-cell-mediated diseases by utilizing synthetic biology and machine learning technologies. Its approach involves discovering novel targets for drug development, which aims to enhance the effectiveness of cancer therapies. Through its research and development efforts, 3T Biosciences is committed to providing healthcare professionals with advanced treatment options for patients facing cancer-related illnesses.

Huiseoul is an e-commerce company based in Seoul, South Korea, specializing in online retail of Korean cosmetic products, particularly targeting the Chinese market. The company offers personalized skincare counseling and develops a robust online platform that facilitates conversational e-commerce. This platform features a forum where beauty consultants provide detailed skincare information in a user-friendly format, allowing customers to receive tailored advice and product recommendations. By combining technology with beauty expertise, Huiseoul aims to enhance the shopping experience for skincare enthusiasts.

Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.

Signal Vine, Inc. is a company that develops an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. The platform features targeted messaging, an intuitive interface, case management, hybrid messaging, and comprehensive reporting and analytics. By leveraging Blended Messaging and incorporating artificial intelligence, Signal Vine enables organizations to send personalized messages to students, alumni, and staff, thereby improving engagement and supporting timely actions. The platform is utilized by K-12 schools, higher education institutions, nonprofit organizations, and government programs to enhance student outcomes, streamline communication, and foster enrollment and persistence. Founded in 2013, the company is headquartered in Alexandria, Virginia.

Indi Molecular, Inc. is a life sciences company based in Culver City, California, that specializes in developing a synthetic class of diagnostic and therapeutic agents known as protein-catalyzed capture (PCC) agents. Founded in 2013 as a spinout from Integrated Diagnostics, the company utilizes “click chemistry” to create PCCs, which possess antibody-like properties with advantages such as improved selectivity, superior binding affinity, and significantly lower molecular weight compared to traditional monoclonal antibodies. These agents serve a dual purpose, functioning as precision-targeted therapeutics and in vivo imaging agents, enhancing the identification of biomarkers in diagnostics and therapeutic applications. The development of PCCs was a collaborative effort with the California Institute of Technology, reflecting the company's commitment to innovation in the life sciences sector.

UniKey Technologies, Inc. is a company that specializes in access control solutions, offering a platform that transforms smartphones into universal electronic keys. Founded in 2010 and based in Winter Park, Florida, the company provides a smart lock system that includes touch-to-open technology, allowing users to unlock doors without removing their smartphones from pockets or purses. UniKey's platform features advanced intelligence that determines whether an authorized user is present before granting access, enhancing security and preventing unauthorized entry. The company collaborates with lock manufacturers, including Kwikset and Weiser, to develop integrated smart lock solutions like Kevo. Additionally, UniKey offers a cloud-based lock management system tailored for multifamily properties and commercial businesses, which simplifies key management and access control across various applications, including residential, hospitality, and automotive sectors.

Amygdala Neurosciences, Inc. is a biopharmaceutical company based in Palo Alto, California, focused on developing pharmacotherapies for addiction treatment and prevention. The company's primary product, ANS-6637, is a selective and reversible aldehyde dehydrogenase 2 (ALDH2) inhibitor designed to prevent pathological dopamine surges associated with substance use disorders while maintaining basal dopamine levels. This mechanism aims to reduce drug-seeking behavior, cravings, and relapse in individuals struggling with various addictions, including nicotine, alcohol, cocaine, and opioids. ANS-6637 has shown promising results in pre-clinical studies and has completed extensive Phase 1 trials, positioning the company for upcoming Phase 2 efficacy studies. Initially, the development efforts are concentrated on smoking cessation, with parallel initiatives for other substance use disorders. Since its incorporation in 2015, Amygdala Neurosciences has been addressing the significant unmet needs in addiction treatment.

Thunder is a technology company that focuses on streamlining the advertising process through its Creative Management Platform. This platform enables advertisers to efficiently create, scale, and manage ad creatives across multiple devices and formats, including display, video, and native ads. By reducing creative friction, Thunder allows brands, media companies, and agencies to produce advertisements more rapidly and effectively. The platform features a user-friendly interface that caters to a range of users, from general marketers to advanced designers, providing tools for testing and targeting creatives to specific audiences across various channels. Thunder serves over 100 notable clients, including InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst, enhancing their advertising capabilities and reach.

Twist Bioscience Corporation is a synthetic biology company that specializes in the manufacture and sale of synthetic DNA-based products. Founded in 2013 and headquartered in South San Francisco, California, the company utilizes a proprietary semiconductor-based DNA synthesis platform that writes DNA on silicon chips, allowing for the rapid and cost-effective production of high-quality synthetic DNA. Twist Bioscience's offerings include synthetic genes, tools for sample preparation, antibody libraries for drug discovery, and DNA as a medium for digital data storage. The company serves various sectors, including healthcare, agriculture, and industrial chemicals, supporting customers in their efforts to enhance lives and promote sustainability. Through its innovative platform, Twist Bioscience aims to overcome traditional inefficiencies in DNA synthesis, enabling researchers to accelerate their projects.

Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.

Welkin Health, Inc. is a San Francisco-based company that develops and operates patient management software designed to enhance care delivery for healthcare organizations. Founded in 2013, its platform automates workflows to guide healthcare teams, ensuring that patients receive timely and appropriate care. The software facilitates communication between health plans, providers, and patients through various channels, including phone, text, video, and email. Additionally, it supports the design and testing of care programs tailored to specific demographics and geographic regions. Welkin Health's cloud-based platform is customizable and scalable, addressing a wide range of healthcare needs such as mental health, substance abuse, diabetes, and oncology, ultimately aiming to foster meaningful relationships between healthcare teams and patients.

3T Biosciences, Inc. is an immunotherapy company established in 2017 and based in Menlo Park, California. The company focuses on developing innovative treatments for cancer and other T-cell-mediated diseases by utilizing synthetic biology and machine learning technologies. Its approach involves discovering novel targets for drug development, which aims to enhance the effectiveness of cancer therapies. Through its research and development efforts, 3T Biosciences is committed to providing healthcare professionals with advanced treatment options for patients facing cancer-related illnesses.

Womply, founded in 2011, is a local commerce platform dedicated to supporting small businesses in navigating the digital landscape. The company offers a suite of applications, marketing tools, and financial services that cater to over 500,000 American businesses. Its unified, browser-based platform focuses on enhancing online presence and reputation management while providing customer and revenue analytics. By leveraging its proprietary data asset, known as the Womply Commerce Graph, Womply delivers a comprehensive view of local commerce, enabling businesses to grow, protect, and simplify their operations effectively.

Mozio, Inc. operates an online airport transportation search and booking engine, enabling travelers to find and reserve various ground transportation options, including shared ride shuttles, private vans, taxis, limousines, and SUVs from airports across the globe. The platform aggregates local transportation services in regions such as the United States, Canada, Latin America, Europe, and Asia, simplifying the process of navigating from the airport to the final destination. Founded in 2012 and based in San Francisco, Mozio also offers API and affiliate programs, allowing travel websites and agents to sell transportation services. The company's mission is to enhance the travel experience by providing users with comprehensive information and the best deals for their ground transportation needs.

InCarda Therapeutics is a clinical-stage biopharmaceutical company based in Newark, California, focused on developing innovative therapies for cardiovascular diseases. The company specializes in an inhaled drug delivery system aimed at treating acute paroxysmal atrial fibrillation, allowing patients to administer treatment quickly during the onset of symptoms. Its lead product, InRhythm, is an inhaled formulation of an antiarrhythmic medication designed to provide rapid relief from arrhythmic events. This method allows for effective medication delivery directly to cardiac tissue, which enhances treatment efficacy and simplifies the management of atrial arrhythmias. InCarda Therapeutics has completed Phase 1 clinical trials and is progressing through Phase 2 with its lead product.

Evidation Health, Inc. specializes in developing digital tools and technologies for healthcare data analytics. The company connects digital health firms with healthcare providers and payers through its advanced platform, which transforms everyday behavior data from various sources, including sensors and devices, into actionable insights regarding health and disease. Its products include a Data Platform that analyzes this high-frequency behavior data and a technology-enabled service called Studies, which facilitates real-world research to support clinical and commercial efforts. By focusing on the interplay between everyday behaviors and health outcomes, Evidation aims to empower individuals and healthcare companies to improve health management outside traditional clinical settings. Founded in 2012 and headquartered in San Mateo, California, the company also operates additional offices in San Francisco and Santa Barbara.

ViewPoint Therapeutics, a biotechnology company founded in 2014 and based in San Francisco, focuses on developing treatments for diseases caused by protein misfolding, particularly cataracts. The company is advancing its research on crystallin stabilizers, which are small molecules designed to prevent and treat age-related cataracts and presbyopia. These stabilizers have shown promise in preclinical models through a systematic screening and optimization process. By targeting protein misfolding, ViewPoint Therapeutics aims to provide effective therapies for common age-related disorders, including cataracts and neurodegenerative diseases, ultimately enhancing treatment options for physicians and their patients.

Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

SensOmics develops innovative technologies aimed at the early detection of pediatric diseases, particularly focusing on autism. By integrating genomics with clinical informatics, electrical engineering, and artificial intelligence, the company creates advanced medical wearable devices. These technologies enable healthcare professionals to diagnose conditions at an early stage, facilitating timely interventions and improving treatment outcomes for affected children. Through its commitment to enhancing pediatric healthcare, SensOmics aims to revolutionize the way diseases are identified and managed in young patients.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

RallyPoint is an online military network that serves approximately 2 million service members, veterans, and their civilian supporters, such as family and recruiters. Its primary mission is to assist members of the military community in leading successful and fulfilling lives by providing a safe environment for networking and career exploration. The platform enables users to connect with other military professionals and discover opportunities within both the military and civilian sectors. Additionally, RallyPoint offers targeted tools for employers seeking to hire from the military community, facilitating connections between transitioning veterans and organizations that value their unique skill sets and experiences. The board is chaired by Bob McDonald, a retired CEO and former Secretary of Veterans Affairs.

Welldoc, Inc. specializes in developing technology solutions for chronic disease management, focusing primarily on diabetes care. Its flagship product, the DiabetesManager platform, allows patients and healthcare providers to coordinate care effectively, promoting self-management and adherence to treatment. This platform includes features such as personalized coaching, medication reminders, out-of-bound alerts, and cloud-based analytics for tracking health metrics. Additionally, Welldoc offers BlueStar, a mobile prescription therapy that provides real-time guidance for diabetes management and clinical decision support for healthcare professionals. The company collaborates with various stakeholders, including payors, employers, pharmaceutical firms, and healthcare systems, to ensure its solutions integrate seamlessly into existing workflows. Founded in 2005 and based in Baltimore, Maryland, with additional offices in Wilmington, Delaware, and Bengaluru, India, Welldoc aims to transform digital health management through innovative technology and artificial intelligence.

Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the development of tissue-integrated sensors and biosensors aimed at enhancing diabetes management and chronic disease care. Founded in 2009, Profusa focuses on creating biointegrated sensors that allow individuals to monitor their unique body chemistry in real time, thereby transforming personal health management. The company's technology is designed to be user-friendly and cost-effective, providing actionable, clinical-grade data to improve health outcomes. Profusa also develops software that offers biofeedback for chronic disease management and promotes healthy living. Its flagship product, Lumee Oxygen, represents a significant advancement in continuous health monitoring within the European market.

Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

Thunder is a technology company that focuses on streamlining the advertising process through its Creative Management Platform. This platform enables advertisers to efficiently create, scale, and manage ad creatives across multiple devices and formats, including display, video, and native ads. By reducing creative friction, Thunder allows brands, media companies, and agencies to produce advertisements more rapidly and effectively. The platform features a user-friendly interface that caters to a range of users, from general marketers to advanced designers, providing tools for testing and targeting creatives to specific audiences across various channels. Thunder serves over 100 notable clients, including InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst, enhancing their advertising capabilities and reach.

Welkin Health, Inc. is a San Francisco-based company that develops and operates patient management software designed to enhance care delivery for healthcare organizations. Founded in 2013, its platform automates workflows to guide healthcare teams, ensuring that patients receive timely and appropriate care. The software facilitates communication between health plans, providers, and patients through various channels, including phone, text, video, and email. Additionally, it supports the design and testing of care programs tailored to specific demographics and geographic regions. Welkin Health's cloud-based platform is customizable and scalable, addressing a wide range of healthcare needs such as mental health, substance abuse, diabetes, and oncology, ultimately aiming to foster meaningful relationships between healthcare teams and patients.

Twist Bioscience Corporation is a synthetic biology company that specializes in the manufacture and sale of synthetic DNA-based products. Founded in 2013 and headquartered in South San Francisco, California, the company utilizes a proprietary semiconductor-based DNA synthesis platform that writes DNA on silicon chips, allowing for the rapid and cost-effective production of high-quality synthetic DNA. Twist Bioscience's offerings include synthetic genes, tools for sample preparation, antibody libraries for drug discovery, and DNA as a medium for digital data storage. The company serves various sectors, including healthcare, agriculture, and industrial chemicals, supporting customers in their efforts to enhance lives and promote sustainability. Through its innovative platform, Twist Bioscience aims to overcome traditional inefficiencies in DNA synthesis, enabling researchers to accelerate their projects.

Thunder is a technology company that focuses on streamlining the advertising process through its Creative Management Platform. This platform enables advertisers to efficiently create, scale, and manage ad creatives across multiple devices and formats, including display, video, and native ads. By reducing creative friction, Thunder allows brands, media companies, and agencies to produce advertisements more rapidly and effectively. The platform features a user-friendly interface that caters to a range of users, from general marketers to advanced designers, providing tools for testing and targeting creatives to specific audiences across various channels. Thunder serves over 100 notable clients, including InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst, enhancing their advertising capabilities and reach.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

Amygdala Neurosciences, Inc. is a biopharmaceutical company based in Palo Alto, California, focused on developing pharmacotherapies for addiction treatment and prevention. The company's primary product, ANS-6637, is a selective and reversible aldehyde dehydrogenase 2 (ALDH2) inhibitor designed to prevent pathological dopamine surges associated with substance use disorders while maintaining basal dopamine levels. This mechanism aims to reduce drug-seeking behavior, cravings, and relapse in individuals struggling with various addictions, including nicotine, alcohol, cocaine, and opioids. ANS-6637 has shown promising results in pre-clinical studies and has completed extensive Phase 1 trials, positioning the company for upcoming Phase 2 efficacy studies. Initially, the development efforts are concentrated on smoking cessation, with parallel initiatives for other substance use disorders. Since its incorporation in 2015, Amygdala Neurosciences has been addressing the significant unmet needs in addiction treatment.

Evidation Health, Inc. specializes in developing digital tools and technologies for healthcare data analytics. The company connects digital health firms with healthcare providers and payers through its advanced platform, which transforms everyday behavior data from various sources, including sensors and devices, into actionable insights regarding health and disease. Its products include a Data Platform that analyzes this high-frequency behavior data and a technology-enabled service called Studies, which facilitates real-world research to support clinical and commercial efforts. By focusing on the interplay between everyday behaviors and health outcomes, Evidation aims to empower individuals and healthcare companies to improve health management outside traditional clinical settings. Founded in 2012 and headquartered in San Mateo, California, the company also operates additional offices in San Francisco and Santa Barbara.

CardioGen Sciences is a biotechnology company that develops and offers gene therapy solutions for orphan-inherited arrhythmogenic diseases. It was founded in 2014 and is based in Palo Alto, California.

Womply, founded in 2011, is a local commerce platform dedicated to supporting small businesses in navigating the digital landscape. The company offers a suite of applications, marketing tools, and financial services that cater to over 500,000 American businesses. Its unified, browser-based platform focuses on enhancing online presence and reputation management while providing customer and revenue analytics. By leveraging its proprietary data asset, known as the Womply Commerce Graph, Womply delivers a comprehensive view of local commerce, enabling businesses to grow, protect, and simplify their operations effectively.

LiquidM Inc. offers a white-labeled mobile advertising management platform designed for agencies and trading desks. Founded in 2013 and based in New York, the company provides a modular, cloud-based software solution that enables users to set up and manage advertisements with tailored settings, targets, and supply partners. The platform is agnostic to third-party integrations, allowing seamless connections with data management platforms, targeting providers, and tracking solutions. By combining media, data, technology, and strategy, LiquidM enhances efficiency and control in media planning and buying, offering deeper insights that drive improved results in the mobile display media marketplace.

CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. Founded in 2003, the company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood test designed to assist healthcare providers in determining whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By leveraging genomic technologies, CardioDx aims to deliver critical information that enhances treatment decisions and improves patient outcomes while also addressing the overall cost of care in the United States.

Signal Vine, Inc. is a company that develops an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. The platform features targeted messaging, an intuitive interface, case management, hybrid messaging, and comprehensive reporting and analytics. By leveraging Blended Messaging and incorporating artificial intelligence, Signal Vine enables organizations to send personalized messages to students, alumni, and staff, thereby improving engagement and supporting timely actions. The platform is utilized by K-12 schools, higher education institutions, nonprofit organizations, and government programs to enhance student outcomes, streamline communication, and foster enrollment and persistence. Founded in 2013, the company is headquartered in Alexandria, Virginia.

Biomimedica is a medical device company based in South San Francisco, California, founded in 2007. The company specializes in developing innovative synthetic cartilage technology aimed at joint repair. Its proprietary material is designed to restore the surface of damaged joints, providing a solution for individuals suffering from joint-related issues. Through its advanced approaches, Biomimedica is contributing to the evolution of joint repair methods in the medical field.

Benefitter Insurance Solution, Inc. provides web-based solutions to assist employers in managing employee health coverage. The company's offerings include tools such as ReformCommunicator, which helps generate required communications about healthcare reform; ReformNavigator, which guides employees through health insurance selection and enrollment; ReformAdvisor, which assesses the suitability of employer-sponsored health coverage; and ReformReadiness, which gathers necessary employee data for insurance quoting. Founded in 2012 and based in San Francisco, California, Benefitter aims to help employers navigate healthcare reform, reduce costs, and enhance employee well-being. As of August 2015, it operates as a subsidiary of HealthMarkets Insurance Company.

Twist Bioscience Corporation is a synthetic biology company that specializes in the manufacture and sale of synthetic DNA-based products. Founded in 2013 and headquartered in South San Francisco, California, the company utilizes a proprietary semiconductor-based DNA synthesis platform that writes DNA on silicon chips, allowing for the rapid and cost-effective production of high-quality synthetic DNA. Twist Bioscience's offerings include synthetic genes, tools for sample preparation, antibody libraries for drug discovery, and DNA as a medium for digital data storage. The company serves various sectors, including healthcare, agriculture, and industrial chemicals, supporting customers in their efforts to enhance lives and promote sustainability. Through its innovative platform, Twist Bioscience aims to overcome traditional inefficiencies in DNA synthesis, enabling researchers to accelerate their projects.

Reify Health, Inc., founded in 2010 and based in Baltimore, Maryland, specializes in cloud-based software designed to enhance health behavior change measurement. Catering primarily to the life sciences industry, the company offers solutions that accelerate the development of new therapies by streamlining clinical research processes. Its flagship product, StudyTeam, supports clinical trial teams by improving enrollment timelines and research efficiency. This software provides research sponsors, contract research organizations (CROs), and clinical research sites with valuable insights into enrollment dynamics, allowing them to prioritize efforts that drive successful clinical outcomes. By reducing administrative burdens, Reify Health enables stakeholders to concentrate on activities that deliver the most significant impact on research productivity and budget management.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

Twist Bioscience Corporation is a synthetic biology company that specializes in the manufacture and sale of synthetic DNA-based products. Founded in 2013 and headquartered in South San Francisco, California, the company utilizes a proprietary semiconductor-based DNA synthesis platform that writes DNA on silicon chips, allowing for the rapid and cost-effective production of high-quality synthetic DNA. Twist Bioscience's offerings include synthetic genes, tools for sample preparation, antibody libraries for drug discovery, and DNA as a medium for digital data storage. The company serves various sectors, including healthcare, agriculture, and industrial chemicals, supporting customers in their efforts to enhance lives and promote sustainability. Through its innovative platform, Twist Bioscience aims to overcome traditional inefficiencies in DNA synthesis, enabling researchers to accelerate their projects.

Maverix Biomics, Inc. offers a cloud-based platform aimed at assisting biologists and life science researchers in managing, analyzing, and visualizing genomic data. The platform is designed to meet the needs of researchers by providing tools for various applications, including RNA-seq analysis, ChIP-seq analysis, and SNP variant detection. By integrating genomic data with biomic information for viral, bacterial, vertebrate, and plant genomes, the platform facilitates a comprehensive approach to research. Maverix Biomics leverages expertise from leading research institutions and technology companies, ensuring that its solutions are built on a foundation of advanced bioinformatics and software development. The company, founded in 2010 and headquartered in San Mateo, California, also has a strategic partnership with QIAGEN to enhance its offerings in the life sciences sector.

Womply, founded in 2011, is a local commerce platform dedicated to supporting small businesses in navigating the digital landscape. The company offers a suite of applications, marketing tools, and financial services that cater to over 500,000 American businesses. Its unified, browser-based platform focuses on enhancing online presence and reputation management while providing customer and revenue analytics. By leveraging its proprietary data asset, known as the Womply Commerce Graph, Womply delivers a comprehensive view of local commerce, enabling businesses to grow, protect, and simplify their operations effectively.

Indi Molecular, Inc. is a life sciences company based in Culver City, California, that specializes in developing a synthetic class of diagnostic and therapeutic agents known as protein-catalyzed capture (PCC) agents. Founded in 2013 as a spinout from Integrated Diagnostics, the company utilizes “click chemistry” to create PCCs, which possess antibody-like properties with advantages such as improved selectivity, superior binding affinity, and significantly lower molecular weight compared to traditional monoclonal antibodies. These agents serve a dual purpose, functioning as precision-targeted therapeutics and in vivo imaging agents, enhancing the identification of biomarkers in diagnostics and therapeutic applications. The development of PCCs was a collaborative effort with the California Institute of Technology, reflecting the company's commitment to innovation in the life sciences sector.

RallyPoint is an online military network that serves approximately 2 million service members, veterans, and their civilian supporters, such as family and recruiters. Its primary mission is to assist members of the military community in leading successful and fulfilling lives by providing a safe environment for networking and career exploration. The platform enables users to connect with other military professionals and discover opportunities within both the military and civilian sectors. Additionally, RallyPoint offers targeted tools for employers seeking to hire from the military community, facilitating connections between transitioning veterans and organizations that value their unique skill sets and experiences. The board is chaired by Bob McDonald, a retired CEO and former Secretary of Veterans Affairs.

LiquidM Inc. offers a white-labeled mobile advertising management platform designed for agencies and trading desks. Founded in 2013 and based in New York, the company provides a modular, cloud-based software solution that enables users to set up and manage advertisements with tailored settings, targets, and supply partners. The platform is agnostic to third-party integrations, allowing seamless connections with data management platforms, targeting providers, and tracking solutions. By combining media, data, technology, and strategy, LiquidM enhances efficiency and control in media planning and buying, offering deeper insights that drive improved results in the mobile display media marketplace.

Lark is a developer of a virtual chronic disease prevention and management platform that offers personalized support and counseling to users. Utilizing advanced artificial intelligence alongside human coaches and connected devices, Lark provides real-time, 24/7 assistance, helping individuals make healthier choices and manage chronic conditions effectively. The company has established CDC-recognized programs, including its Diabetes Prevention Program, Wellness Program, Diabetes Care Program, and Hypertension Program, which collectively serve 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in 11 peer-reviewed journals and analyst reports. Founded in 2011 by Julia Hu and Jeff Zira, Lark is headquartered in Mountain View, California.

Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the development of tissue-integrated sensors and biosensors aimed at enhancing diabetes management and chronic disease care. Founded in 2009, Profusa focuses on creating biointegrated sensors that allow individuals to monitor their unique body chemistry in real time, thereby transforming personal health management. The company's technology is designed to be user-friendly and cost-effective, providing actionable, clinical-grade data to improve health outcomes. Profusa also develops software that offers biofeedback for chronic disease management and promotes healthy living. Its flagship product, Lumee Oxygen, represents a significant advancement in continuous health monitoring within the European market.

Keepsafe Software Inc. is a company that specializes in digital privacy solutions, providing applications designed to protect personal content on mobile devices. Founded in 2012 and based in San Francisco, California, Keepsafe offers a suite of apps, including Keepsafe Photos, Keepsafe Documents, and AppLock, which allow users to secure and manage their private photos, videos, and documents. The software is available for both iOS and Android platforms and is designed to prevent unauthorized access to sensitive data, enabling users to maintain ownership over their digital privacy while providing options for safe sharing. Keepsafe aims to simplify the management of personal information in the digital realm, making privacy as straightforward as it is in the physical world.

Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

Evidation Health, Inc. specializes in developing digital tools and technologies for healthcare data analytics. The company connects digital health firms with healthcare providers and payers through its advanced platform, which transforms everyday behavior data from various sources, including sensors and devices, into actionable insights regarding health and disease. Its products include a Data Platform that analyzes this high-frequency behavior data and a technology-enabled service called Studies, which facilitates real-world research to support clinical and commercial efforts. By focusing on the interplay between everyday behaviors and health outcomes, Evidation aims to empower individuals and healthcare companies to improve health management outside traditional clinical settings. Founded in 2012 and headquartered in San Mateo, California, the company also operates additional offices in San Francisco and Santa Barbara.

Synecor LLC is a medical device company based in Durham, North Carolina, with additional locations in California and North Carolina. Founded in 2000 by Dr. Richard Stack, the company emerged from collaborative relationships in the field of interventional cardiology. Synecor specializes in developing innovative medical device technologies across various specialties, including obesity and spine therapeutics. The company focuses on creating minimally invasive device-based treatments, bioerodible vascular stent platforms for coronary artery disease, and solutions for managing arrhythmias. Additionally, Synecor is advancing a technology platform designed to access and treat the gastrointestinal system through natural orifices. By addressing unmet medical needs, Synecor aims to offer effective treatment options that enable patients to begin their care promptly, thereby improving the likelihood of successful outcomes.

HealthTap is a virtual-first healthcare provider that delivers affordable urgent and primary care services to all Americans, regardless of insurance status. The company aims to ensure equitable access to quality physician care across the nation. HealthTap's platform allows users to connect with doctors through various means, including limited texting, video appointments, and urgent care consultations with the next available physician. Additionally, the service offers free responses to health inquiries from a network of volunteer doctors across different specialties, empowering users to select and maintain a long-term primary care physician for their ongoing health needs.

Proteus Digital Health, Inc. was a digital medicines company headquartered in Redwood City, California, founded in 2001. It specialized in developing innovative products and services that integrated pharmaceuticals with ingestible sensors, wearable technology, mobile applications, and cloud computing. The company's offerings included ingestible sensors that communicated medication adherence, wearable sensor patches to monitor physiological responses, and digital platforms for data analytics. These technologies aimed to empower patients and their families in managing health, while providing healthcare providers with tools to enhance decision-making and optimize treatment outcomes. In November 2020, Proteus Digital Health filed for Chapter 11 bankruptcy and subsequently ceased operations.

Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called "HDL Therapy," which is based on the Company's understanding of high-density lipoprotein, or HDL, function.

Reify Health, Inc., founded in 2010 and based in Baltimore, Maryland, specializes in cloud-based software designed to enhance health behavior change measurement. Catering primarily to the life sciences industry, the company offers solutions that accelerate the development of new therapies by streamlining clinical research processes. Its flagship product, StudyTeam, supports clinical trial teams by improving enrollment timelines and research efficiency. This software provides research sponsors, contract research organizations (CROs), and clinical research sites with valuable insights into enrollment dynamics, allowing them to prioritize efforts that drive successful clinical outcomes. By reducing administrative burdens, Reify Health enables stakeholders to concentrate on activities that deliver the most significant impact on research productivity and budget management.

Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. Founded in 2003, the company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood test designed to assist healthcare providers in determining whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By leveraging genomic technologies, CardioDx aims to deliver critical information that enhances treatment decisions and improves patient outcomes while also addressing the overall cost of care in the United States.

Biomimedica is a medical device company based in South San Francisco, California, founded in 2007. The company specializes in developing innovative synthetic cartilage technology aimed at joint repair. Its proprietary material is designed to restore the surface of damaged joints, providing a solution for individuals suffering from joint-related issues. Through its advanced approaches, Biomimedica is contributing to the evolution of joint repair methods in the medical field.

Reify Health, Inc., founded in 2010 and based in Baltimore, Maryland, specializes in cloud-based software designed to enhance health behavior change measurement. Catering primarily to the life sciences industry, the company offers solutions that accelerate the development of new therapies by streamlining clinical research processes. Its flagship product, StudyTeam, supports clinical trial teams by improving enrollment timelines and research efficiency. This software provides research sponsors, contract research organizations (CROs), and clinical research sites with valuable insights into enrollment dynamics, allowing them to prioritize efforts that drive successful clinical outcomes. By reducing administrative burdens, Reify Health enables stakeholders to concentrate on activities that deliver the most significant impact on research productivity and budget management.

Terra Bella, originally known as Skybox Imaging, is a private company based in Mountain View, California, specializing in high-resolution satellite imagery and analytics services. Co-founded in 2009 by Dan Berkenstock, Julian Mann, John Fenwick, and Ching-Yu Hu, the company operates the SkySat-1 satellite, which captures detailed panchromatic and multispectral images of the Earth. Terra Bella's offerings include analyzing the movement of goods and people, providing visual data on supply chains, shipping activities, industrial operations, and humanitarian relief efforts. Through its advanced imaging technology, the company delivers critical insights to various sectors, enhancing decision-making and operational efficiency.

Keepsafe Software Inc. is a company that specializes in digital privacy solutions, providing applications designed to protect personal content on mobile devices. Founded in 2012 and based in San Francisco, California, Keepsafe offers a suite of apps, including Keepsafe Photos, Keepsafe Documents, and AppLock, which allow users to secure and manage their private photos, videos, and documents. The software is available for both iOS and Android platforms and is designed to prevent unauthorized access to sensitive data, enabling users to maintain ownership over their digital privacy while providing options for safe sharing. Keepsafe aims to simplify the management of personal information in the digital realm, making privacy as straightforward as it is in the physical world.

HealthTap is a virtual-first healthcare provider that delivers affordable urgent and primary care services to all Americans, regardless of insurance status. The company aims to ensure equitable access to quality physician care across the nation. HealthTap's platform allows users to connect with doctors through various means, including limited texting, video appointments, and urgent care consultations with the next available physician. Additionally, the service offers free responses to health inquiries from a network of volunteer doctors across different specialties, empowering users to select and maintain a long-term primary care physician for their ongoing health needs.

ICON Aircraft, Inc. is a manufacturer based in Vacaville, California, that specializes in designing, developing, and producing light consumer sport aircraft. Founded in 2004, the company aims to make personal flight more accessible through innovative and safe aircraft, including its flagship model, the A5. The A5 is an amphibious sport plane recognized for its advanced aeronautical engineering, unique design, and safety features, including being the world's first production aircraft that is spin-resistant. ICON Aircraft also operates an online store selling various aviation-related gear and apparel. The company's mission is to democratize personal flight and 3-D mobility, fostering a culture that encourages intelligent risk-taking and collaboration among its team members. With a commitment to delivering technologically advanced and consumer-friendly products, ICON Aircraft seeks to inspire a global community of aviation enthusiasts.

HealthTap is a virtual-first healthcare provider that delivers affordable urgent and primary care services to all Americans, regardless of insurance status. The company aims to ensure equitable access to quality physician care across the nation. HealthTap's platform allows users to connect with doctors through various means, including limited texting, video appointments, and urgent care consultations with the next available physician. Additionally, the service offers free responses to health inquiries from a network of volunteer doctors across different specialties, empowering users to select and maintain a long-term primary care physician for their ongoing health needs.

ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company based in Westlake Village, California, focused on developing immune-based therapies for the treatment of various cancers. The company specializes in dendritic cell (DC) immunotherapies, with notable products including ICT-107, which targets glioblastoma multiforme, a severe brain cancer; ICT-140, aimed at ovarian cancer; and ICT-121, designed to address recurrent glioblastoma and other solid tumors by targeting CD133 markers. Additionally, ImmunoCellular is advancing Steam-to-T-Cell immunotherapies to enhance cancer treatment outcomes. The company has established license agreements with prominent institutions, including the California Institute of Technology and The Johns Hopkins University, to support its research and development efforts.

Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

Ooma, Inc. is a communications services company that specializes in creating connected experiences for both businesses and consumers. Headquartered in Sunnyvale, California, Ooma offers a smart cloud-based software-as-a-service (SaaS) platform that provides a range of communication solutions. For businesses, Ooma delivers advanced voice and collaboration features through its offerings, such as Ooma Office and Ooma Enterprise, which include services like call recording, voicemail transcription, and mobile integration. For residential customers, Ooma provides home communications solutions like Ooma Telo, which serves as a primary phone line with high-definition voice quality and smart security features. The company also offers a variety of products, including mobile apps and security solutions, allowing users to monitor and control their home environments. Ooma generates revenue primarily through subscription services, distributing its products through direct sales, retailers, and online channels. Established in 2003, Ooma continues to innovate in the realm of connected communications and security.

Rapidscan Pharma Solutions, Inc. is a company founded in 2010 that specializes in the development, manufacturing, and marketing of Regadenoson, a pharmacological stress agent utilized in the diagnosis and risk assessment of cardiovascular disease. The company holds licenses to sell Regadenoson in various regions, including Europe, Latin America, Japan, Australia, New Zealand, and Israel. This product plays a critical role in the diagnosis of coronary artery disease, a condition affecting over 15 million individuals in Europe, with approximately 1.5 million patients undergoing myocardial perfusion imaging procedures annually. As of January 2017, Rapidscan operates as a subsidiary of GE Healthcare, benefiting from its resources and expertise in the healthcare sector.

Provade, Inc. specializes in enterprise vendor management systems, focusing on workforce management and procurement solutions. Established in 2004 and headquartered in Milwaukee, Wisconsin, with additional offices in California, the United Kingdom, and Australia, the company serves clients globally, including enterprise technology firms, financial institutions, and manufacturing businesses. Provade's offerings include managed services for contingent workforce management, professional services to enhance procurement strategies, and an on-demand procurement platform that integrates with major ERP systems like Oracle and PeopleSoft. The company's tools enable organizations to analyze and manage their contingent workforce and related expenditures efficiently, providing users with mobile applications for timesheet and expense management. By leveraging its services, businesses can achieve measurable savings, increased visibility, and streamlined operations in their workforce and procurement processes. As of early 2018, Provade operates as a subsidiary of Smart ERP Solutions Inc.

CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, focused on developing genomic tests for cardiovascular diseases. Founded in 2003, the company specializes in assessing conditions such as coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood test designed to assist healthcare providers in determining whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By leveraging genomic technologies, CardioDx aims to deliver critical information that enhances treatment decisions and improves patient outcomes while also addressing the overall cost of care in the United States.

OfferIQ is a company that focuses on providing paper-free coupon services, facilitating the distribution of in-store shopping discounts directly to consumers through their mobile devices. The company operates a Virtual Incentive Platform that connects incentives to consumers' existing debit and credit cards, allowing these discounts to be redeemed seamlessly during the payment process. This innovative approach enables retailers to implement the service without requiring modifications to their existing point-of-sale systems or additional staff training, streamlining the coupon redemption experience in physical stores.